Serum tumor necrosis factor-α does not mediate endotoxin-induced myocardial depression in rabbits

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 2 39-2, 1996, Pages

  Nishikawa, Yasuhiro ^a   Mathison, John ^c   Lew, Wilbur Y W ^b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

cytokines; sepsis; ventricular function

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE VOLUME; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEPSIS;

EID: 0029972438     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.2.h485     Document Type: Article

References (34)

1. Alexander, H. R., B. C. Sheppard, J. C. Jensen, H. N. Langstein, C. M. Buresh, D. Venzon, E. C. Walker, D. L. Fraker, M. C. Stovroff, and J. A. Norton. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J. Clin. Invest. 88: 34-39, 1991.
2. Ashkenazi, A., S. A. Marsters, D. J. Capon, S. M. Chamow, I. S. Figari, D. Pennica, D. V. Goeddel, M. A. Palladino, and D. H. Smith. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88: 10535-10539, 1991.
3. Balligand, J. L., D. Ungureanu, R. A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T. W. Smith. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319, 1993.
4. Beutler, B., I. W. Milsark, and A. C. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science Wash. DC 229: 869-871, 1985.
5. Calandra, T., J. D. Baumgartner, G. E. Grau, M. M. Wu, P. H. Lambert, J. Schellekens, J. Verhoef, and M. P. Glauser. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J. Infect. Dis. 161: 982-987, 1990.
6. Eichenholz, P. W., P. Q. Eichacker, W. D. Hoffman, S. M. Banks, J. E. Parrillo, R. L. Danner, and C. Natanson. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H668-H675, 1992.
7. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148: 2724-2730, 1992.
8. Fiedler, V. B., I. Loof, E. Sander, V. Voehringer, C. Galanos, and M. A. Fournel. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J. Lab. Clin. Med. 120: 574-588, 1992.
9. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science Wash. DC 257: 387-389, 1992.
10. Gamble, J. R., J. M. Harlan, S. J. Klebanoff, and M. A. Vadas. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82: 8667-8671, 1985.
11. Girardin, E., G. E. Grau, J. M. Dayer, P. Roux-Lombard, and P. H. Lambert. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319: 397-400, 1988.
12. Giroir, B. P., J. W. Horton, D. J. White, K. L. McIntyre, and C. Q. Lin. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am. J. Physiol 267 (Heart Circ. Physiol. 36): H118-H124, 1994.
13. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Allen, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693-698, 1992.
14. Gulick, T., M. K. Chung, S. J. Pieper, L. G. Lange, and G. F. Schreiner. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc. Natl Acad. Sci. USA 86: 6753-6757.1989.
15. Hung, J., andW. Y. W. Lew. Temporal sequence of endotoxin-induced systolic and diastolic myocardial depression in rabbits Am. J. Physiol 265 (Heart Circ. Physiol. 34): H810-H819, 1993
16. Hung, J., andW. Y. W. Lew. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ. Res. 73: 125-134, 1993.
17. Jin, H., R. Yang, S. A. Marsters, S. A. Bunting, F. M. Wurm, S. M. Chamow, and A. Ashkenazi. Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J. Infect. Dis. 170: 1323-1326, 1994.
18. Kapadia, S., G. Torre-Amione, T. Yokoyama, and D. L. Mann. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-α in vitro. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H517-H525, 1995.
19. Klebanoff, S. J., M. A. Vadas, J. M. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, and A. M. Waltersdorph. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 136. 4220-4225, 1986.
20. Mathison, J. C., E. Wolfson, and R. J. Ulevitch. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81: 1925-1937, 1988.
21. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318: 1481-1486, 1988.
22. Natanson, C., P. W. Eichenholz, R. L. Danner, P. Q. Eichacker, W. D. Hoffman, G. C. Kuo, S. M. Banks, T. J. MacVittie, and J. E. Parrillo. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169: 823-832, 1989.
23. Nishikawa, Y., andW. Y. W. Lew. Endotoxin-induced left ventricular depression is blocked by nitrogen mustard or dimethylthiourea in rabbits. Am. J. Physiol. 269 (Heart Circ Physiol. 38): H1098-H1105, 1995
24. Pagani, F. D., L. S. Baker, C. Hsi, M. Knox, M. P. Fink, and M. S. Visner. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J. Clin. Invest. 90: 389-398, 1992.
25. Raetz, C. R., R. J. Ulevitch, S. D. Wright, C. H. Sibley, A. Ding, and C. F. Nathan. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5: 2652-2660, 1991.
26. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature Lond. 364: 798-802, 1993.
27. 2+-independent nitric oxide synthase in the myocardium Br. J. Pharmacol. 105: 575-580, 1992.
28. Tanaka, N., T. Kita, K. Kasai, and T. Nagano. The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock. Virchows Arch. 424: 273-277, 1994
29. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, A. Zentella, and J. D. Albert. Shock and tissue injury induced by recombinant human cachectin. Science Wash. DC 234: 470-474, 1986.
30. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature Lond. 330: 662-664, 1987.
31. Vincent, J. L., J. Bakker, G. Marecaux, L. Schandene, R. J. Kahn, and E. Dupont. Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101: 810-815, 1992.
32. Waage, A., A. Halstensen, and T. Espevik. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-357, 1987.
33. Walley, K. R., P. C. Hebert, Y. Wakai, P. G. Wilcox, J. D. Road, and D. J. Cooper. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J. Appl. Physiol. 76: 1060-1067, 1994.
34. Yokoyama, T., L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J. Clin. Invest. 92: 2303-2312, 1993.